BRSK1
Basic information
Region (hg38): 19:55282072-55312562
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BRSK1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 28 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 0 | 1 |
Variants in BRSK1
This is a list of pathogenic ClinVar variants found in the BRSK1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-55287033-A-G | not specified | Uncertain significance (Mar 06, 2023) | ||
19-55289548-C-T | not specified | Uncertain significance (May 22, 2023) | ||
19-55289583-G-T | not specified | Uncertain significance (Oct 18, 2021) | ||
19-55302756-T-C | not specified | Uncertain significance (May 29, 2024) | ||
19-55302809-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
19-55303314-G-C | not specified | Uncertain significance (Sep 22, 2023) | ||
19-55303352-G-A | not specified | Uncertain significance (May 14, 2024) | ||
19-55303394-C-G | not specified | Uncertain significance (Jun 30, 2024) | ||
19-55303704-C-T | Benign (Apr 30, 2018) | |||
19-55303705-C-T | not specified | Uncertain significance (Oct 29, 2021) | ||
19-55303711-G-A | not specified | Uncertain significance (May 17, 2023) | ||
19-55303723-C-T | not specified | Uncertain significance (Jan 02, 2024) | ||
19-55303759-G-C | not specified | Uncertain significance (Oct 29, 2021) | ||
19-55303768-G-A | not specified | Uncertain significance (Aug 28, 2024) | ||
19-55303795-C-T | not specified | Uncertain significance (Nov 18, 2022) | ||
19-55303796-G-A | not specified | Uncertain significance (Jul 02, 2024) | ||
19-55304067-G-A | not specified | Uncertain significance (Apr 09, 2024) | ||
19-55304584-G-T | not specified | Uncertain significance (Aug 09, 2021) | ||
19-55304695-C-A | not specified | Uncertain significance (Jul 20, 2022) | ||
19-55304732-G-T | not specified | Uncertain significance (Apr 26, 2024) | ||
19-55304833-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
19-55304842-G-A | not specified | Uncertain significance (May 22, 2023) | ||
19-55304864-A-G | not specified | Uncertain significance (Jul 25, 2023) | ||
19-55305326-A-G | not specified | Uncertain significance (Dec 17, 2023) | ||
19-55305518-A-C | not specified | Uncertain significance (Nov 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BRSK1 | protein_coding | protein_coding | ENST00000309383 | 19 | 30462 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000185 | 125736 | 0 | 8 | 125744 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.94 | 240 | 484 | 0.496 | 0.0000336 | 4964 |
Missense in Polyphen | 36 | 95.257 | 0.37792 | 913 | ||
Synonymous | -0.267 | 208 | 203 | 1.02 | 0.0000147 | 1629 |
Loss of Function | 5.24 | 3 | 37.8 | 0.0794 | 0.00000209 | 421 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000625 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000219 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000270 | 0.0000264 |
Middle Eastern | 0.000219 | 0.000217 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine-protein kinase that plays a key role in polarization of neurons and centrosome duplication. Phosphorylates CDC25B, CDC25C, MAPT/TAU, RIMS1, TUBG1, TUBG2 and WEE1. Following phosphorylation and activation by STK11/LKB1, acts as a key regulator of polarization of cortical neurons, probably by mediating phosphorylation of microtubule-associated proteins such as MAPT/TAU at 'Thr-529' and 'Ser-579'. Also regulates neuron polarization by mediating phosphorylation of WEE1 at 'Ser-642' in post-mitotic neurons, leading to down-regulate WEE1 activity in polarized neurons. In neurons, localizes to synaptic vesicles and plays a role in neurotransmitter release, possibly by phosphorylating RIMS1. Also acts as a positive regulator of centrosome duplication by mediating phosphorylation of gamma- tubulin (TUBG1 and TUBG2) at 'Ser-131', leading to translocation of gamma-tubulin and its associated proteins to the centrosome. Involved in the UV-induced DNA damage checkpoint response, probably by inhibiting CDK1 activity through phosphorylation and activation of WEE1, and inhibition of CDC25B and CDC25C. {ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15150265, ECO:0000269|PubMed:20026642, ECO:0000269|PubMed:21985311}.;
- Pathway
- LKB1 signaling events
(Consensus)
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.409
- rvis_EVS
- -0.8
- rvis_percentile_EVS
- 12.24
Haploinsufficiency Scores
- pHI
- 0.385
- hipred
- Y
- hipred_score
- 0.572
- ghis
- 0.586
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.826
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Brsk1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein phosphorylation;cellular response to DNA damage stimulus;mitotic G2 DNA damage checkpoint;neurotransmitter secretion;axonogenesis;associative learning;response to UV;response to ionizing radiation;regulation of neuron projection development;establishment of cell polarity;neuron differentiation;intracellular signal transduction;regulation of synaptic plasticity;regulation of axonogenesis;centrosome duplication;microtubule cytoskeleton organization involved in establishment of planar polarity;synaptic vesicle cycle;regulation of synaptic vesicle clustering
- Cellular component
- nucleus;nucleoplasm;cytoplasm;centrosome;synaptic vesicle;cell junction;presynaptic active zone;distal axon
- Molecular function
- magnesium ion binding;protein serine/threonine kinase activity;ATP binding;protein kinase binding;gamma-tubulin binding;tau protein binding;tau-protein kinase activity